A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients
Figure 7.Sensitivity of low- or high-risk patients to five common chemotherapy agents. The y-axis represents 50% inhibitory concentration (IC50). (A) Bexarotene; (B) Bicalutamide; (C) Bortezomib; (D) Bryostatin; (E) Rapamycin.